1Dept. of Chemotherapy, Tokyo Metropolitan Komagome Hospital.
Sequential administration of methotrexate (MTX) and 5-fluorouracil (5-FU) shows promise for gastric and colorectal cancers. Optimal timing intervals between these chemotherapy drugs are being investigated to improve patient outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: